Top

Published in:

01-10-2011 | American Society of Breast Surgeons

Distance of Breast Cancer From the Skin and Nipple Impacts Axillary Nodal Metastases

Authors: Bijan Ansari, MD, PhD, Marilyn J. Morton, DO, Darcy L. Adamczyk, MD, Katie N. Jones, MD, Julie K. Brodt, MS, CNP, Amy C. Degnim, MD, James W. Jakub, MD, Christine M. Lohse, MS, Judy C. Boughey, MD

Published in: Annals of Surgical Oncology | Issue 11/2011

Abstract

Background

Lymphatic drainage of the breast is via subareolar and dermal lymphatics. The aim of this study was to determine whether distance of breast cancers from the skin and/or distance from the nipple impacts the likelihood of axillary nodal metastases.

Methods

A retrospective review was performed of sonographically visible T1 and T2 breast cancers with breast and axillary surgery performed at Mayo Clinic, Rochester, MN. Distance of tumor from the nipple was reviewed. Ultrasounds were reviewed to measure the distance of tumor from the skin.

Results

Data were collected on 233 eligible T1 or T2 breast cancers, of which 177 (76%) were node negative and 56 (24%) were node positive. On multivariable analysis, tumor stage and lymphovascular invasion, as well as decreasing distance of the tumor from the nipple and decreasing distance of the tumor from the skin, were significantly associated with axillary lymph node positivity. Each 1-cm decrease in the distance of the tumor from the nipple was associated with a 23% increased likelihood of positive lymph nodes (odds ratio 1.23; P = .003). Each 1-mm decrease in the distance of the tumor from the skin was associated with a 15% increased likelihood of positive lymph nodes (odds ratio 1.15; P = .003).

Conclusion

T1 and T2 breast cancers located closer to the skin and those located closer to the nipple have a higher incidence of metastases to axillary lymph nodes. Distance from the skin and distance from the nipple should be considered when estimating a patient’s likelihood of axillary nodal positivity.

Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52:1551–7.PubMedCrossRef

Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966–78.PubMed

Luini A, Gatti G, Ballardini B, Zurrida S, Galimberti V, Veronesi P, et al. Development of axillary surgery in breast cancer. Ann Oncol. 2005;16:259–62.PubMedCrossRef

Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–7.PubMedCrossRef

Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am. 1990;70:937–62.PubMed

Cavalli LR. Molecular markers of breast axillary lymph node metastasis. Expert Rev Mol Diagn. 2009;9:441–54.PubMedCrossRef

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg. 2000;191:1–6.PubMedCrossRef

Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, van der Wall E, Licht J, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001;136:1059–63.PubMedCrossRef

Patani NR, Dwek MV, Douek M. Predictors of axillary lymph node metastasis in breast cancer: a systematic review. Eur J Surg Oncol. 2007;33:409–19.PubMedCrossRef

10.

Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK. Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat. 2010;42:30–6.PubMedCrossRef

11.

Bevilacqua JL, Kattan MW, Fey JV, Cody HS, 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25:3670–9.PubMedCrossRef

12.

Veerapong J, Boughey JC, Mittendorf EA, Harrell R, Bassett R, Ross M, et al. A validated risk assessment of sentinel lymph node involvement in breast cancer patients. Ann Surg Oncol. 2011;18:S59 (Abstract).

13.

Memorial Sloan Kettering Cancer Center breast nomogram webpage. Available: http://www.mskcc.org/applications/nomograms/breast/BreastSLNodeMetastasisPage.aspx. Accessed April 1, 2011.

14.

MD Anderson Cancer Center nomogram. Available: http://www3.mdanderson.org/app/medcalc/bc_nomogram3/index.cfm?pagename=sln. Accessed April 1, 2011.

15.

Suami H, Pan WR, Taylor GI. Historical review of breast lymphatic studies. Clin Anat. 2009;22:531–6.PubMedCrossRef

16.

Cunningham JE, Jurj AL, Oman L, Stonerock AE, Nitcheva DK, Cupples TE. Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin? Breast Cancer Res Treat. 2006;100:319–28.PubMedCrossRef

17.

Lewis EI, Ozonoff A, Nguyen CP, Kim M, Slanetz PJ. Breast cancer close to the nipple: does this increase the risk of nodal metastasis at diagnosis? Can Assoc Radiol J. doi:10.1016/j.carj.2010.03.007 2008; May 26 [Epub ahead of print].

18.

Chao C, Edwards MJ, Abell T, Wong SL, Simpson D, McMasters KM. Palpable breast carcinomas: a hypothesis for clinically relevant lymphatic drainage in sentinel lymph node biopsy. Breast J. 2003;9:26–32.PubMedCrossRef

19.

Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–72.PubMedCrossRef

20.

Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, Sigurdson ER, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65:34–9.PubMedCrossRef

21.

Tafra L, Essner R, Brenner RJ, Giuliano AE. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management. Am Surg. 1996;62:395–9.PubMed

22.

Skinner KA, Silberman H, Sposto R, Silverstein MJ. Palpable breast cancers are inherently different from nonpalpable breast cancers. Ann Surg Oncol. 2001;8:705–10.PubMedCrossRef

23.

Wasif N, Garreau J, Terando A, Kirsch D, Mund DF, Giuliano AE. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg. 2009;75:970–5.PubMed

24.

Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.PubMed

25.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.PubMedCrossRef

Title: Distance of Breast Cancer From the Skin and Nipple Impacts Axillary Nodal Metastases
Authors: Bijan Ansari, MD, PhD
Marilyn J. Morton, DO
Darcy L. Adamczyk, MD
Katie N. Jones, MD
Julie K. Brodt, MS, CNP
Amy C. Degnim, MD
James W. Jakub, MD
Christine M. Lohse, MS
Judy C. Boughey, MD
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 11/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-1957-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Distance of Breast Cancer From the Skin and Nipple Impacts Axillary Nodal Metastases

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2011

Sensitivity of Axillary Specimen X-ray to Predict Nodal Count and Positivity

Introduction of Eric Whitacre, MD, President 2010–2011: American Society of Breast Surgeons Annual Meeting 2011

Prophylactic and Therapeutic Mastectomy in BRCA Mutation Carriers: Can the Nipple Be Preserved?

Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer

Preoperative Predictors of Nipple–Areola Complex Involvement for Patients Undergoing Mastectomy for Breast Cancer

American Society of Breast Surgeons Presidential Address: Three Simple Ideas